To our knowledge, this is the first study analyzing the association of AD concerns with amyloid burden in cognitively unimpaired individuals, adjusting for key demographics (age, sex, and education), anxiety and depressive symptoms, self‐reported and performance‐based cognitive performance, parental history of dementia, and genetic risk (APOE ε4). This evidence concerns the gene APOE and Alzheimer disease.